Differential regulation of FGF-1 and-2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells

被引:26
作者
Fernig, DG
Chen, HL
Rahmoune, H
Descamps, S
Boilly, B
Hondermarck, H [1 ]
机构
[1] Univ Lille 1, UPRES Biol Dev EA1033, Equipe Factors Croissance, F-59655 Villeneuve Dascq, France
[2] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England
基金
英国医学研究理事会;
关键词
D O I
10.1006/bbrc.1999.2028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growth of the malignant human mammary MDA-MB-231 cells is stimulated by fibroblast growth factor-1 (FGF-1) but not by FGF-2. When these cells are cultured in the presence of chlorate, an inhibitor of heparan sulfate (HS) sulfation, their proliferation is stimulated by both FGF-1 and FGF-2. We analyzed the interactions of FGF-1 and FGF-2 with HS purified from the cell layer and the culture medium of control and chlorate-treated MDA-MB-231 cells. The HS from the cell layer bound FGF-1 with faster association kinetics than the RS from the culture medium, and so had a higher affinity for FGF-1. Chlorate treatment had no significant effect on the FGF-1 binding kinetics of the HS. In contrast to FGF-1, chlorate treatment of the cells significantly altered the FGF-8 binding kinetics. The HS from untreated cells possessed two binding sites for FGF-2, one with fast association kinetics (k(ass) 470,000 to 610,000 m(-1) S-1) and a high affinity (K-d 46 to 70 nM) and one with slower association kinetics (k(ass) 74,000 to 100,000 M-1 s(-1)) and a lower affinity (K-d 290 to 400 nM). HS from chlorate-treated cells possessed just a single binding site for FGF-2 with fast association kinetics (k(ass) 270,000 to 290,000 M-1 s(-1)) and a high affinity (K-d 41 to 57 nM). These results show that there is a relationship between the binding kinetics of FGFs and their ability to stimulate cell growth. (C) 2000 Academic Press.
引用
收藏
页码:770 / 776
页数:7
相关论文
共 44 条
[1]   COMPARATIVE EXPRESSION OF FIBROBLAST GROWTH-FACTOR MESSENGER-RNAS IN BENIGN AND MALIGNANT BREAST DISEASE [J].
ANANDAPPA, SY ;
WINSTANLEY, JHR ;
LEINSTER, S ;
GREEN, B ;
RUDLAND, PS ;
BARRACLOUGH, R .
BRITISH JOURNAL OF CANCER, 1994, 69 (04) :772-776
[2]  
AVIEZER D, 1994, J BIOL CHEM, V269, P114
[3]   Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases [J].
Bame, KJ ;
Hassall, A ;
Sanderson, C ;
Venkatesan, I ;
Sun, C .
BIOCHEMICAL JOURNAL, 1998, 336 :191-200
[4]   SYNTHESIS OF BASIC FIBROBLAST GROWTH-FACTOR UPON DIFFERENTIATION OF RAT MAMMARY EPITHELIAL TO MYOEPITHELIAL-LIKE CELLS IN CULTURE [J].
BARRACLOUGH, R ;
FERNIG, DG ;
RUDLAND, PS ;
SMITH, JA .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 144 (02) :333-344
[5]   DIFFERENTIAL TEMPORAL AND SPATIAL GENE-EXPRESSION OF FIBROBLAST GROWTH-FACTOR FAMILY MEMBERS DURING MOUSE MAMMARY-GLAND DEVELOPMENT [J].
COLEMANKRNACIK, S ;
ROSEN, JM .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (02) :218-229
[6]   Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells [J].
Delehedde, M ;
Deudon, E ;
Boilly, B ;
Hondermarck, H .
EXPERIMENTAL CELL RESEARCH, 1996, 229 (02) :398-406
[7]   KINETICS OF PROTEIN-PROTEIN INTERACTIONS AT THE SURFACE OF AN OPTICAL BIOSENSOR [J].
EDWARDS, PR ;
GILL, A ;
POLLARDKNIGHT, DV ;
HOARE, M ;
BUCKLE, PE ;
LOWE, PA ;
LEATHERBARROW, RJ .
ANALYTICAL BIOCHEMISTRY, 1995, 231 (01) :210-217
[8]  
Fernig David G., 1994, Progress in Growth Factor Research, V5, P353, DOI 10.1016/0955-2235(94)00007-8
[9]  
Forsten KE, 1997, J CELL PHYSIOL, V172, P209, DOI 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO
[10]  
2-S